Univest
Univest
  • Markets

Nifty Healthcare Prediction for Tomorrow, 23 July 2026: Healthcare Stocks Track Pharma’s Sharp 1.31 Percent Reversal

  • July 22, 2026
  • Posted by: Ankit Jaiswal
  • Category: News
No Comments
Nifty Healthcare Prediction for Tomorrow, 23 July

Nifty Healthcare prediction for tomorrow 23 July 2026: healthcare stocks tracked Nifty Pharma’s sharp 1.31 percent Wednesday fall to 25,751.15, reversing its own two-session gains.

Nifty healthcare prediction for tomorrow: Healthcare stocks tracked a sharp Wednesday reversal in the closely related Nifty Pharma index, which fell 1.31 percent to 25,751.15, reversing its own two-session gains, with Dr Reddy’s Laboratories falling 1.92 percent among the day’s notable stock-specific declines. This nifty healthcare prediction for tomorrow is built on Friday, 10 July 2026’s closing data, the last completed session before markets reopen on Monday, 13 July 2026.

Kunal Singla, Associate Director at Univest, notes that the Nifty Healthcare prediction for tomorrow reflects a genuinely surprising reversal, since pharma’s own decline came precisely on a day when defensive rotation clearly favoured FMCG instead, suggesting Wednesday’s severe escalation triggered a more selective, rather than uniformly defensive, market reaction.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Market Recap Behind the Nifty healthcare prediction for tomorrow
  • Nifty healthcare prediction for tomorrow: Trend and Key Levels
  • A Selective Reaction, Not a Uniform Defensive Rotation
  • Key Triggers in the Nifty healthcare prediction for tomorrow
  • Related Sectors to Watch
  • Risks to the Nifty healthcare prediction for tomorrow
  • Conclusion
  • FAQs on the Nifty healthcare prediction for tomorrow
    • What is the Nifty Healthcare prediction for tomorrow, 23 July 2026?
    • Which analyst gave the Nifty Healthcare prediction for tomorrow?
    • Why did pharma fall while FMCG rallied on the same day?
    • Which stock drove pharma’s decline on Wednesday?

Market Recap Behind the Nifty healthcare prediction for tomorrow

Nifty Pharma, the closest tracked proxy for the healthcare sector, opened at 25,935.45, touched a high of 25,935.45 and a low of 25,545.60 before closing at 25,751.15, reversing its own two-session rebound from earlier this week. Dr Reddy’s Laboratories fell 1.92 percent to Rs 1,182.80, among the notable stock-specific declines dragging the broader index lower.

Nifty healthcare prediction for tomorrow: Trend and Key Levels

Trend: Bearish Below 25,935

Kunal Singla notes Nifty Pharma’s own 25,545 support and 25,935 resistance zone serves as the closest available reference for the Nifty Healthcare prediction for tomorrow, given the substantial constituent overlap between the two indices.

A Selective Reaction, Not a Uniform Defensive Rotation

The US carried out its 11th straight night of strikes against Iran, while Iranian drones struck oil facilities in neighbouring Kuwait and Iran retaliated by targeting sites in Bahrain, Kuwait and Jordan. Critically, Saudi crude’s alternate shipping route through the Bab el-Mandeb Strait is now itself under threat of blockade by Iran’s Houthi allies, leaving no clearly safe route. Brent crossed 92 dollars a barrel, a five-week high, and India VIX jumped 5.63 percent to 13.31, a genuine fear spike. Nifty Auto was the session’s lone major sectoral gainer. Kunal Singla notes that pharma’s own decline, even as FMCG rallied sharply the same session, suggests Wednesday’s severe escalation triggered a more selective market reaction than a simple flight to all defensives, with stock-specific factors like Dr Reddy’s own weakness also playing a genuine role.

Key Triggers in the Nifty healthcare prediction for tomorrow

These triggers dominate the outlook heading into Monday, 13 July 2026:

  • Whether pharma’s reversal extends: A further decline Thursday would confirm this is more than a single-day pullback.
  • Dr Reddy’s own specific weakness: Worth tracking for whether it’s an isolated stock-specific issue or reflects broader sector concerns.
  • HDFC Bank fell a further 1.09 percent to Rs 753.15 on Wednesday, its third straight decline, now down roughly 8 percent cumulatively since Friday’s close.

Talk to a SEBI Registered Investment Advisor Before Your Next Trade

Related Sectors to Watch

Healthcare’s reversal is best understood relative to FMCG’s own continued defensive strength the same session.

Nifty Pharma: Nifty Pharma closed at 25,751.15, down 1.31 percent, the closest available proxy.

Nifty FMCG: Nifty FMCG rose 0.80 percent the same session, a genuine divergence among defensives worth noting.

Risks to the Nifty healthcare prediction for tomorrow

These factors can invalidate this outlook:

  • Continued sector-specific weakness: If Dr Reddy’s own decline reflects broader concerns, it could weigh on the sector further.
  • US regulatory news: Any adverse FDA or pricing decision would be a clear sector-specific negative.
  • A deeper reversal: Would suggest Tuesday’s own rebound was more fragile than initially appeared.

Download the Univest iOS App or Univest Android App to get daily sector research and SEBI registered analyst views on Univest.

Conclusion

The Nifty Healthcare prediction for tomorrow, 23 July 2026, is bearish below 25,935, after the sector reversed its own two-session gains sharply even as FMCG rallied the same session. Kunal Singla flags Nifty Pharma’s own levels as the closest reference for the Nifty Healthcare prediction for tomorrow, with Dr Reddy’s own trajectory worth watching heading into Thursday.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

FAQs on the Nifty healthcare prediction for tomorrow

What is the Nifty Healthcare prediction for tomorrow, 23 July 2026?

Ans. The Nifty Healthcare prediction for tomorrow, 23 July 2026, is bearish below 25,935. Healthcare stocks tracked Nifty Pharma’s sharp 1.31 percent Wednesday fall, reversing its own two-session gains.

Which analyst gave the Nifty Healthcare prediction for tomorrow?

Ans. Kunal Singla, Associate Director at Univest, has shared the Nifty Healthcare prediction for tomorrow, tracking it closely against Nifty Pharma given significant constituent overlap.

Why did pharma fall while FMCG rallied on the same day?

Ans. Both sectors are typically considered defensives, yet pharma fell 1.31 percent while FMCG rose 0.80 percent on Wednesday, a divergence the Nifty Healthcare prediction for tomorrow attributes to Dr Reddy’s own stock-specific weakness alongside a more selective, rather than uniform, defensive rotation pattern.

Which stock drove pharma’s decline on Wednesday?

Ans. Dr Reddy’s Laboratories fell 1.92 percent to Rs 1,182.80 on Wednesday, among the notable stock-specific declines the Nifty Healthcare prediction for tomorrow flags as worth tracking for whether it’s isolated or reflects broader sector concerns.



News
Author: Ankit Jaiswal
Ankit Jaiswal is the Senior Research Analyst at Univest, leading the platform's in-house equity research desk and serving as the editorial reviewer for all research and blog content published at univest.in. With 11+ years of experience in Indian equity markets, he oversees stock recommendations, earnings analysis, sector coverage, and ensures every published article meets SEBI Research Analyst Regulations. He holds a Bachelor of Commerce (B.Com) from St. Xavier's College, Kolkata — one of India's most prestigious commerce institutions — and has cleared CMT Level 2 from the CMT Association, a globally recognised certification in technical analysis and market research. His research methodology combines fundamental analysis (earnings quality, balance sheet strength, management commentary) with advanced technical analysis (chart patterns, momentum indicators, market structure) — giving Univest's retail investors a dual-lens approach that most Indian research platforms lack. Ankit is among the most comprehensively certified analysts in Indian financial media, holding five NISM certifications: Series-XV (Research Analyst), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-VI (Depository Operations), and Series-V-A (Mutual Fund Distributors). At Univest — India's SEBI-registered research and advisory platform — Ankit's responsibilities include leading the research team, finalising stock recommendations published across Pro Lite, Pro Super, and Pro Gold advisory services, and maintaining editorial oversight of all YMYL financial content published on the blog.

Leave a Reply Cancel reply